Former CEO of Biosensors International to Serve as Advisor to Cannabis Company With Growing Operations in California and Puerto Rico
DORADO, Puerto Rico, June 13, 2018 (GLOBE NEWSWIRE) — Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or, the “Company”) announced today that it has appointed Jeffrey B. Jump to the Company’s Advisory Board, where he will serve alongside Puerto Rico’s former Secretary of Agriculture Juan Salas, businessman Alexander Zhilenkov and security consultant Luis F. Toledo.
“I am both honored and excited to join Green Spirit’s Advisory Board at a time when this company is on the precipice of tremendous growth,” said Jump. “With consumer sales in the medicinal and recreational cannabis marketplaces already established and expanding with new dispensary locations, and the Company’s development of proprietary formulations (patents pending) for both consumer and pharmaceutical use, I believe Green Spirit is headed for tremendous success in the still-nascent cannabis industry, and the opportunity to be a part of that is one I could not pass up.”
A German-born U.S. citizen, Jump is a 39-year veteran of the international medical devices industry, most recently serving as CEO of Biosensors Inernational at the company’s headquarters in Switzerland. During 13 years at Biosensors, Jump guided the company from a single-product start-up operation to become a diversified international public medical devices company with $300 million in annual revenue. Jump served on the Board of Directors at PneumRx, a leader in the field of interventional pulmonology, that was acquired by BTG plc in 2014 for $475 million, and also on the Board of Symetis, the Swiss structural heart company that was acquired by Boston Scientific Corporation in 2017 for $435 million.
Jump holds a B.S. degree from Indiana University, a Masters of Science degree from London Business School, and a Masters of Science in Research from the University of South Australia.
About Green Spirit Industries Inc.
Green Spirit Industries Inc. (OTC Pink:GSRX), through its subsidiaries, is in the business of acquiring, developing and operating retail cannabis dispensaries, and is in the process of expanding its business to include the cultivation, extraction, manufacture and delivery of cannabis and cannabinoid products. To date, Green Spirit has acquired and operates four cannabis dispensaries in California and Puerto Rico, and has acquired four additional pre-qualified locations in Puerto Rico, all of which are under construction with expected openings later this year. The Company expanded its California operations into the cultivation/growing, extraction/processing and cannabinoid manufacturing businesses during the first quarter of 2018 through joint ventures in which it holds majority stakes.
Forward-Looking Statements
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.
Contact:
Paul Gendreau
PGPR
[email protected]
678-807-7945